| Literature DB >> 31354792 |
Priscila S N de Oliveira1, Luiz L Coutinho2, Aline S M Cesar3, Wellison J da Silva Diniz4, Marcela M de Souza5, Bruno G Andrade1, James E Koltes5, Gerson B Mourão3, Adhemar Zerlotini6, James M Reecy5, Luciana C A Regitano1.
Abstract
Fatty acid (FA) content affects the sensorial and nutritional value of meat and plays a significant role in biological processes such as adipogenesis and immune response. It is well known that, in beef, the main FAs associated with these biological processes are oleic acid (C18:1 cis9, OA) and conjugated linoleic acid (CLA-c9t11), which may have beneficial effects on metabolic diseases such as type 2 diabetes and obesity. Here, we performed differential expression and co-expression analyses, weighted gene co-expression network analysis (WGCNA) and partial correlation with information theory (PCIT), to uncover the complex interactions between miRNAs and mRNAs expressed in skeletal muscle associated with FA content. miRNA and mRNA expression data were obtained from skeletal muscle of Nelore cattle that had extreme genomic breeding values for OA and CLA. Insulin and MAPK signaling pathways were identified by WGCNA as central pathways associated with both of these fatty acids. Co-expression network analysis identified bta-miR-33a/b, bta-miR-100, bta-miR-204, bta-miR-365-5p, bta-miR-660, bta-miR-411a, bta-miR-136, bta-miR-30-5p, bta-miR-146b, bta-let-7a-5p, bta-let-7f, bta-let-7, bta-miR 339, bta-miR-10b, bta-miR 486, and the genes ACTA1 and ALDOA as potential regulators of fatty acid synthesis. This study provides evidence and insights into the molecular mechanisms and potential target genes involved in fatty acid content differences in Nelore beef cattle, revealing new candidate pathways of phenotype modulation that could positively benefit beef production and human consumption.Entities:
Keywords: Bos indicus; conjugated linoleic acid; integrative genomics; mRNA; miRNA; oleic acid
Year: 2019 PMID: 31354792 PMCID: PMC6637853 DOI: 10.3389/fgene.2019.00651
Source DB: PubMed Journal: Front Genet ISSN: 1664-8021 Impact factor: 4.599
Genomic estimated breeding values (GEBVs) and number of normalized mapped miRNA reads for Nelore steers with divergent fatty acid content groups.
| Groups1 | GEBVs | miRNA mapped reads | Groups2 | GEBVs | miRNA mapped reads |
|---|---|---|---|---|---|
|
| |||||
| H-OA1 | 2.11 | 970,350 | L-OA1 | −7.06 | 605,324 |
| H-OA2 | 1.54 | 745,742 | L-OA2 | −4.98 | 1,308,497 |
| H-OA3 | 3.20 | 1,009,408 | L-OA3 | −5.51 | 703,560 |
| H-OA4 | 3.25 | 1,051,535 | L-OA4 | −2.41 | 525,015 |
| H-OA5 | 2.16 | 1,052,657 | L-OA5 | −1.54 | 594,924 |
| H-OA6 | 2.08 | 1,289,704 | L-OA6 | −2.95 | 563,260 |
| H-OA7 | 1.58 | 610,678 | L-OA7 | −2.43 | 349,772 |
| H-OA8 | 1.92 | 564,255 | L-OA8 | −7.03 | 557,486 |
| H-OA9 | 4.14 | 555,136 | L-OA9 | −3.48 | 656,226 |
| H-OA10 | 2.61 | 607,145 | L-OA10 | −2.67 | 685,506 |
| H-OA11 | 3.89 | 1,035,882 | L-OA11 | −1.63 | 690,291 |
| H-OA12 | 2.84 | 520,790 | L-OA12 | −8.07 | 748,090 |
| H-OA13 | 1.76 | 584,448 | L-OA13 | −4.14 | 689,313 |
| H-OA14 | * | * | L-OA14 | −7.36 | 602,604 |
| H-OA15 | * | * | L-OA15 | −2.91 | 732,483 |
|
|
|
|
|
|
|
|
| |||||
| H-CLA1 | 0.008 | 439,844 | L-CLA1 | −0.008 | 457,706 |
| H-CLA2 | 0.012 | 1,152,736 | L-CLA2 | −0.013 | 532,780 |
| H-CLA3 | 0.008 | 938,908 | L-CLA3 | −0.017 | 988,632 |
| H-CLA4 | 0.012 | 1308,497 | L-CLA4 | −0.011 | 521,652 |
| H-CLA5 | 0.011 | 235,852 | L-CLA5 | −0.010 | 300,196 |
| H-CLA6 | 0.016 | 874,538 | L-CLA6 | −0.009 | 1,264,789 |
| H-CLA7 | 0.022 | 976,093 | L-CLA7 | −0.016 | 685,506 |
| H-CLA8 | 0.025 | 1,039,805 | L-CLA8 | −0.013 | 702,016 |
| H-CLA9 | 0.009 | 555,136 | L-CLA9 | −0.015 | 605,442 |
| H-CLA10 | 0.009 | 918,555 | L-CLA10 | −0.013 | 677,737 |
| H-CLA11 | 0.012 | 675,360 | L-CLA11 | −0.009 | 522,944 |
| H-CLA12 | 0.012 | 772,395 | L-CLA12 | −0.010 | 658,923 |
| H-CLA13 | 0.019 | 713,501 | L-CLA13 | −0.010 | 752,121 |
| H-CLA14 | 0.019 | 500,697 | L-CLA14 | −0.018 | 1,306,312 |
| H-CLA15 | 0.014 | 636,795 | L-CLA15 | −0.010 | 511,704 |
|
|
|
|
|
|
|
1Nelore samples of high (H) oleic acid (OA) and conjugated linoleic acid (CLA) groups.
2Nelore samples of low (L) oleic acid (OA) and conjugated linoleic acid (CLA) groups.
*Data not available.
Differentially expressed miRNAs identified by miRDeep2 for Nelore steers with divergent fatty acid content groups and the number of predicted target genes.
| miRNA | log2FC1 | padj2 | High3 | Low4 | Predicted target genes5 |
|---|---|---|---|---|---|
|
| |||||
| bta-miR-126-5p | 0.4346 | 0.0987 | 3,334.235 | 4,682.251 | 3,619 |
|
| |||||
| bta-miR-2419-5p | −1.18 | 0.0041 | 16,108.8 | 4,182.543 | 365 |
1log2 fold change.
2False discovery rate adjusted p-values by Benjamini–Hochberg (1995) methodology.
3,4Normalized miRNA mean counts of high and low fatty acid content groups.
5Number of predicted target genes by TargetsSan and miRanda software.
Signaling pathways of miRNA module eigengenes (MEs) negatively correlated with mRNA MEs for Nelore steers with divergent fatty acid content groups.
| Group | mRNA MEs | Corr |
| miRNA MEs | Signaling pathways2 |
|
|---|---|---|---|---|---|---|
|
| paletvioletred3 | −0.7 | 0.01 | Magenta | Insulin resistance | 6.23e−06 |
| grey | −0.6 | 0.04 | Black | MAPK signaling pathway | 5.54e−07 | |
| lightsteelblue1 | −0.8 | 0.00 | Turquoise | Insulin resistance | 1.64e−04 | |
| bisque4 | −0.7 | 0.00 | ||||
|
| coral1 | −0.7 | 0.00 | Turquoise | AMPK signaling pathway | 7.11e−07 |
| mediumpurple2 | −0.6 | 0.01 | ||||
| darkolivegreen | −0.7 | 0.00 | Pink | Insulin signaling pathway | 9.76e−08 | |
| orangered | −0.5 | 0.04 | ||||
| lightcyan1 | −0.5 | 0.05 | Blue | Proteoglycans in cancer | 1.17e−04 | |
| mediumorchid | −0.6 | 0.01 | ||||
| lightcyan1 | −0.6 | 0.03 | Yellow | Wnt signaling pathway | 1.84e−05 | |
| lightcyan1 | −0.7 | 0.00 | Green | Insulin signaling pathway | 2.89e−04 | |
|
| cyan | −0.6 | 0.03 | Turquoise | ns | * |
| brown | −0.6 | 0.02 | Red | Insulin resistance | 7.9e−05 | |
| plum2 | −0.6 | 0.03 | Blue | Insulin resistance | 1.1e−05 | |
| turquoise | −0.6 | 0.03 | ||||
| darkred | −0.7 | 0.00 | Brown | ns | * | |
| steelblue | −0.5 | 0.04 | ||||
| thistle1 | −0.6 | 0.02 | Black | Insulin signaling pathway | 2.73e−07 | |
|
| purple | −0.5 | 0.04 | Blue | Insulin signaling pathway | 6.68e−06 |
| white | −0.5 | 0.04 | ||||
| orange | −0.5 | 0.04 | Red | MAPK signaling pathway | 1.71e−04 |
1Nominal p-value.
2Signaling pathways of target genes from hub miRNAs selected based on greatest module membership values.
*NS, non-significant.
Figure 1Co-expression networks of H-OA group from Nelore cattle. Colored diamonds represent the top five hub miRNAs within each module, and colored rectangles represent the signaling pathways associated (p-value ≤ 0.10) with hub miRNA target genes.
Figure 2Co-expression networks of L-OA group from Nelore cattle. Colored diamonds represent the top five hub miRNAs within each module, and colored rectangles represent the signaling pathways associated (p-value ≤ 0.10) with hub miRNA target genes.
Figure 3Co-expression networks of H-CLA group from Nelore cattle. Colored diamonds represent the top five hub miRNAs within each module, and colored rectangles represent the signaling pathways associated (p-value ≤ 0.10) with hub miRNA target genes.
Figure 4Co-expression networks of L-CLA group from Nelore cattle. Colored diamonds represent the top five hub miRNAs within each module, and colored rectangles represent the signaling pathways associated (p-value ≤ 0.10) with hub miRNA target genes.
Top negative and positive extreme hubbing genes groups for oleic acid (OA) and conjugated linoleic acid (CLA) content.
| Ensembl gene ID | Gene symbol | Description | DH* |
|---|---|---|---|
|
| |||
| ENSBTAG00000040485 |
| Theg spermatid protein | −905 |
| ENSBTAG00000031806 |
| Zinc finger protein 48 | −826 |
| ENSBTAG00000007692 | – | – | −799 |
| ENSBTAG00000044830 | bta-mir-339a | bta-mir-339a | −770 |
| ENSBTAG00000007956 |
| Frequently rearranged advanced T-cell lymphomas 1 | −753 |
|
| |||
| ENSBTAG00000015100 |
| ATPase H+ transporting V0 subunit e1 | 2946 |
| ENSBTAG00000025221 | TEX30 | Testis expressed 30 | 2,925 |
| ENSBTAG00000014337 |
| Eukaryotic translation initiation factor 2 subunit 3 | 2,911 |
| ENSBTAG00000044066 |
| Chromosome 1 open reading frame | 2,903 |
| ENSBTAG00000002772 |
| Galactose-3- | 2,902 |
|
| |||
| ENSBTAG00000005578 |
| Lysine acetyltransferase 5 | −2,126 |
| ENSBTAG00000046307 |
| CCAAT enhancer binding protein delta | −2,112 |
| ENSBTAG00000003849 |
| G protein nucleolar 2 | −2,060 |
| ENSBTAG00000045822 | – | – | −1,997 |
| ENSBTAG00000002634 |
| Transmembrane protein 115 | −1,987 |
|
| |||
| ENSBTAG00000013600 |
| Proteasome assembly chaperone | 1,848 |
| ENSBTAG00000015042 |
| WD repeat domain | 1,809 |
| ENSBTAG00000032684 |
| Tctex1 domain containing 2 | 1,794 |
| ENSBTAG00000006321 |
| RNA 3′-terminal phosphate | 1,740 |
| ENSBTAG00000045544 |
| Eukaryotic translation initiation factor | 1,692 |
*DH, differential hubbing.
Top negative and positive genes identified by regulatory impact factor 1 (RIF1) and regulatory impact factor 2 (RIF2) score for oleic acid (OA) content.
| Ensembl gene ID | Gene symbol | Description | RIF1 |
|---|---|---|---|
|
| |||
| ENSBTAG00000000020 |
| Transient receptor potential cation channel subfamily V member 3 | −0.046 |
| ENSBTAG00000000030 |
| RAD52 motif containing 1 | −0.046 |
| ENSBTAG00000000102 |
| G protein-coupled receptor 75 | −0.046 |
| ENSBTAG00000000008 |
| Potassium voltage-gated channel subfamily J member 1 | −0.046 |
| ENSBTAG00000000168 | – | – | −0.046 |
|
| |||
| ENSBTAG00000012927 |
| Aldolase, fructose-bisphosphate A | 94.532 |
| ENSBTAG00000011424 |
| Tropomyosin 2 (beta) | 69.720 |
| ENSBTAG00000013921 |
| Creatine kinase | 27.167 |
| ENSBTAG00000009707 |
| Myosin light chain 1 | 23.357 |
| ENSBTAG00000005373 |
| Tropomyosin 1 (alpha) | 22.028 |
|
| |||
| bta-miR-10b | bta-mir-10b | bta-mir-10b | −1.377 |
| ENSBTAG00000007782 |
| Myotilin | −0.238 |
| ENSBTAG00000009696 |
| Alpha-actinin-2 | −0.074 |
| ENSBTAG00000000678 |
| Cold shock domain containing E1 | −0.060 |
| ENSBTAG00000006419 |
| Troponin T | −0.050 |
|
| |||
| ENSBTAG00000012927 |
| Aldolase, fructose-bisphosphate A | 106.069 |
| ENSBTAG00000011424 |
| Tropomyosin 2 (beta) | 54.632 |
| ENSBTAG00000013921 |
| Creatine kinase | 28.422 |
| ENSBTAG00000005373 |
| Tropomyosin 1 (alpha) | 22.117 |
| ENSBTAG00000009707 |
| Myosin light chain 1 | 16.740 |
*RIF1 and RF2 scores are presented as Z-score-normalized values.
Top negative and positive genes identified by regulatory impact factor 1 (RIF1) and regulatory impact factor 1 (RIF2) score for conjugated linoleic acid (CLA) content.
| Ensembl gene ID | Gene symbol | Description | RIF1 |
|---|---|---|---|
|
| |||
| ENSBTAG00000000164 |
| Gonadotropin releasing hormone 1 | −0.0633 |
| ENSBTAG00000000582 |
| Lymphocyte antigen 6 complex | −0.0633 |
| ENSBTAG00000000982 |
| Chromosome 22 c3orf84 homolog | −0.0633 |
| ENSBTAG00000000031 |
| Transient receptor potential cation channel subfamily V member 4 | −0.0633 |
| ENSBTAG00000000535 |
| Pecanex homolog 2 | −0.0633 |
|
| |||
| ENSBTAG00000026986 |
| Titin | 25.8861 |
| ENSBTAG00000006907 |
| Nebulin | 29.2850 |
| ENSBTAG00000011424 |
| Tropomyosin 2 (beta) | 36.2570 |
| ENSBTAG00000013921 |
| Creatine kinase | 36.8083 |
| ENSBTAG00000012927 |
| Aldolase, fructose-bisphosphate A | 89.4190 |
|
| |||
| ENSBTAG00000012927 |
| Aldolase, fructose-bisphosphate A | −108.25 |
| ENSBTAG00000013921 |
| Creatine kinase | −38.19 |
| ENSBTAG00000011424 |
| Tropomyosin 2 (beta) | −38.08 |
| ENSBTAG00000005373 |
| Tropomyosin 1 (beta) | −24.17 |
| ENSBTAG00000046332 |
| Actin alpha 1 | −20.98 |
|
| |||
| ENSBTAG00000018204 |
| Myosin heavy chain 1 | 11.5144 |
| ENSBTAG00000005353 |
| Desmin | 6.2929 |
| ENSBTAG00000006907 |
| Nebulin | 4.5481 |
| ENSBTAG00000006823 |
| Cardiomyopathy associated 5 | 1.9259 |
| ENSBTAG00000017183 |
| PDZ and LIM domain 3 | 1.3030 |
*RIF1 and RIF2 scores are presented as Z-score-normalized values.
Top 10 regulators identified by phenotypic impact factor (PIF) analysis with FDR adjusted p-value for oleic acid (OA) and conjugated linoleic acid (CLA) content.
| Ensembl gene ID | Gene symbol | Description | PIF | adj. |
|---|---|---|---|---|
|
| ||||
| bta-miR-10b | bta-miR-10b | bta-miR-10b | 66,197 | 1.10e−01* |
| ENSBTAG00000046332 |
| Actin, alpha 1, skeletal muscle | 20,402 | 1.27e−005 |
| ENSBTAG00000026986 |
| Titin | 8,820 | 4.81e−007 |
| ENSBTAG00000018204 |
| Myosin, heavy chain 1, skeletal muscle, adult | 7,401 | 8.64e−008 |
| ENSBTAG00000012927 |
| Aldolase, fructose-bisphosphate A | 7,199 | 9.68e−006 |
| ENSBTAG00000011424 | – | – | 4,547 | 2.42e−005 |
| ENSBTAG00000013921 |
| Creatine kinase, M-type | 3,610 | 5.41e−006 |
| bta-miR-486 | bta-miR-486 | bta-mir-486 | 3,506 | 4.27e−001* |
| ENSBTAG00000006907 |
| Nebulin | 2,864 | 1.91e−007 |
| ENSBTAG00000021218 |
| Myosin light chain, phosphorylatable, fast skeletal muscle | 2,111 | 6.31e−005 |
|
| ||||
| bta-miR-10b | bta-miR-10b | bta-miR-10b | 92,224 | 9.53e−003 |
| ENSBTAG00000046332 |
| Actin, alpha 1, skeletal muscle | 39,297 | 1.48e−009 |
| ENSBTAG00000012927 |
| Aldolase, fructose-bisphosphate A | 21,787 | 7.32e−004 |
| ENSBTAG00000026986 |
| Titin | 18,487 | 2.16e−007 |
| ENSBTAG00000018204 |
| Myosin, heavy chain 1, skeletal muscle, adult | 14,134 | 1.65e−011 |
| ENSBTAG00000011424 | – | – | 9,845 | 2.65e−004 |
| ENSBTAG00000013921 |
| Creatine kinase, M-type | 7,206 | 1.41e−006 |
| ENSBTAG00000006907 |
| Nebulin | 5,455 | 6.68e−007 |
| ENSBTAG00000021218 |
| Myosin light chain, phosphorylatable, fast skeletal muscle | 4,229 | 1.27e−004 |
| bta-mir-486 | bta-mir-486 | bta-mir-486 | 3,777 | 1.18e−003 |
*Non-significant adj p-values.